Reducing Distress And Improving Glycemic Control In Adults With Type 1 Diabetes.

减轻成人 1 型糖尿病患者的痛苦并改善血糖控制。

基本信息

项目摘要

DESCRIPTION (provided by applicant): Diabetes distress (DD) refers to the unique emotional burdens, worries and concerns that are part of the spectrum of patient experience when managing a severe, demanding chronic disease like diabetes. High DD is very common and persistent over time among those with diabetes, and it has been significantly associated with poor glycemic control, poor self-care, low diabetes self-efficacy, and poor quality of life, even after controlling for clinical depression. The vast majority of research in DD has focused on adults with type 2 diabetes, a metabolic disease based on genetic predisposition, obesity, sedentary lifestyle and insulin resistance. Far less research has focused on the very different experiences of DD among adults with type 1 diabetes: an autoimmune disease that requires much more intensive and intrusive management than type 2. The proposed research addresses two major gaps in the clinical care of adult patients with type 1 diabetes and DD: to develop a practical, reliable and valid measure of DD for adult patients with type 1 diabetes, with empirically defined cut- points for high DD; and to test a unique, pragmatic, theory based program to reduce high DD among at-risk, poorly controlled type 1 adults. Following a brief measurement study to establish reliable cut-points for high DD, we propose a 2-arm clinical trial to test the comparative effectiveness of an adaptation of Problem Solving Therapy, which now includes a comprehensive focus on emotion, behavior and cognition, with a current standard of care - enhanced diabetes education. Primary outcomes are reduced DD and improved glycemic control. The innovative intervention uses a variety of modalities, some based on electronic and social media (e.g., real time web-based group calls, web-based blogging, personal telephone contact) to enhance participation and retention, and reduce patient burden. We will also assess the impact of selective mediating and moderating variables, collect measures of cost, and will link the findings to dissemination and implementation using RE-AIM.
描述(由申请人提供):糖尿病困扰(DD)指的是患者在处理糖尿病等严重、苛刻的慢性疾病时所经历的独特的情感负担、担忧和担忧。高DD在糖尿病患者中非常常见并持续一段时间,即使在控制了临床抑郁之后,它也与血糖控制差、自我护理差、糖尿病自我效能低和生活质量差密切相关。DD的绝大多数研究都集中在患有2型糖尿病的成年人身上,2型糖尿病是一种基于遗传易感性、肥胖、久坐的生活方式和胰岛素抵抗的代谢性疾病。很少有研究关注成人1型糖尿病患者DD的截然不同的经历:这是一种自身免疫性疾病,需要比2型糖尿病患者更密集和更具侵入性的治疗。这项拟议的研究解决了成人1型糖尿病患者和DD患者临床护理中的两个主要差距:为1型糖尿病成人患者开发一种实用、可靠和有效的DD测量方法,根据经验确定高DD的临界点;以及测试一种独特、实用、基于理论的计划,以降低高危、控制不佳的1型成年人的DD水平。在一项简短的测量研究为高DD建立可靠的切入点之后,我们提议进行一项双臂临床试验,以测试改编的问题解决疗法的比较有效性,该疗法现在包括对情绪、行为和认知的全面关注,与当前标准的加强护理的糖尿病教育。主要结果是减少了DD和改善了血糖控制。这种创新的干预方式使用了多种方式,其中一些基于电子和社交媒体(例如,基于网络的实时群呼、基于网络的博客、个人电话联系),以增强参与度和留存,并减轻患者负担。我们还将评估选择性调解和缓和变量的影响,收集成本衡量标准,并将利用RE-AIM将结果与传播和实施联系起来。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

LAWRENCE FISHER其他文献

LAWRENCE FISHER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('LAWRENCE FISHER', 18)}}的其他基金

Evaluating Affective and Unified Behavioral Approaches to Reducing Diabetes Distress and Improving Glycemic Control
评估减少糖尿病困扰和改善血糖控制的情感和统一行为方法
  • 批准号:
    10381712
  • 财政年份:
    2019
  • 资助金额:
    $ 61.77万
  • 项目类别:
Evaluating Affective and Unified Behavioral Approaches to Reducing Diabetes Distress and Improving Glycemic Control
评估减少糖尿病困扰和改善血糖控制的情感和统一行为方法
  • 批准号:
    9904621
  • 财政年份:
    2019
  • 资助金额:
    $ 61.77万
  • 项目类别:
Reducing Distress And Improving Glycemic Control In Adults With Type 1 Diabetes.
减轻成人 1 型糖尿病患者的痛苦并改善血糖控制。
  • 批准号:
    8601699
  • 财政年份:
    2012
  • 资助金额:
    $ 61.77万
  • 项目类别:
Reducing Distress And Improving Glycemic Control In Adults With Type 1 Diabetes.
减轻成人 1 型糖尿病患者的痛苦并改善血糖控制。
  • 批准号:
    9186536
  • 财政年份:
    2012
  • 资助金额:
    $ 61.77万
  • 项目类别:
Reducing Distress And Improving Glycemic Control In Adults With Type 1 Diabetes.
减轻成人 1 型糖尿病患者的痛苦并改善血糖控制。
  • 批准号:
    8782480
  • 财政年份:
    2012
  • 资助金额:
    $ 61.77万
  • 项目类别:
Reducing Distress And Improving Glycemic Control In Adults With Type 1 Diabetes.
减轻成人 1 型糖尿病患者的痛苦并改善血糖控制。
  • 批准号:
    8444733
  • 财政年份:
    2012
  • 资助金额:
    $ 61.77万
  • 项目类别:
Depression, self-management and ethnicity in diabetes
糖尿病患者的抑郁、自我管理和种族
  • 批准号:
    6606455
  • 财政年份:
    2003
  • 资助金额:
    $ 61.77万
  • 项目类别:
Daily Depressive Affect & Disease Management in Diabetes
日常抑郁影响
  • 批准号:
    6910809
  • 财政年份:
    2003
  • 资助金额:
    $ 61.77万
  • 项目类别:
Reducing Dirstress and Improving Self-Care in Diabetes
减少糖尿病患者的痛苦并改善自我护理
  • 批准号:
    7575149
  • 财政年份:
    2003
  • 资助金额:
    $ 61.77万
  • 项目类别:
Daily Depressive Affect & Disease Management in Diabetes
日常抑郁影响
  • 批准号:
    6727696
  • 财政年份:
    2003
  • 资助金额:
    $ 61.77万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 61.77万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 61.77万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 61.77万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 61.77万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 61.77万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 61.77万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 61.77万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 61.77万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 61.77万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 61.77万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了